<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu CH</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>National Heart Lung and Blood Institute</funding><funding>Tri-Service General Hospital</funding><pagination>2382</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9917043</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(3)</volume><pubmed_abstract>Tumor recurrence poses a significant challenge to the clinical management of stage I lung adenocarcinoma after curative surgical resection. Matrix metalloproteinases (MMPs) increase expression and correlate with recurrence and metastasis in surgically resected non-small cell lung cancer. However, the impact of MMPs on survival outcome varies, and their roles in patients with stage I lung adenocarcinoma remain unclear. In two discovery cohorts, we first analyzed 226 stage I-II lung adenocarcinoma cases in the GSE31210 cohort using a clustering-based method and identified a 150-gene MMP cluster with increased expression in tumors associated with worse survival outcomes. A similar analysis was performed on 517 lung adenocarcinoma cases in the Cancer Genome Atlas cohort. A 185-gene MMP cluster</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes.</pubmed_title><pmcid>PMC9917043</pmcid><funding_grant_id>AI-133351</funding_grant_id><funding_grant_id>TSGH-E-111235</funding_grant_id><funding_grant_id>Health HL-125128</funding_grant_id><pubmed_authors>Liu CH</pubmed_authors><pubmed_authors>Di YP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Matrix Metallopeptidase-Gene Signature Predicts Stage I Lung Adenocarcinoma Survival Outcomes.</name><description>Tumor recurrence poses a significant challenge to the clinical management of stage I lung adenocarcinoma after curative surgical resection. Matrix metalloproteinases (MMPs) increase expression and correlate with recurrence and metastasis in surgically resected non-small cell lung cancer. However, the impact of MMPs on survival outcome varies, and their roles in patients with stage I lung adenocarcinoma remain unclear. In two discovery cohorts, we first analyzed 226 stage I-II lung adenocarcinoma cases in the GSE31210 cohort using a clustering-based method and identified a 150-gene MMP cluster with increased expression in tumors associated with worse survival outcomes. A similar analysis was performed on 517 lung adenocarcinoma cases in the Cancer Genome Atlas cohort. A 185-gene MMP cluster</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-25T19:20:47.181Z</modification><creation>2025-04-06T07:58:33.521Z</creation></dates><accession>S-EPMC9917043</accession><cross_references><pubmed>36768704</pubmed><doi>10.3390/ijms24032382</doi></cross_references></HashMap>